CausalSentinel

Protein Dossier — MPO (Myeloperoxidase)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Sleep duration 0.016 0.00469 6.58e-04 Inverse variance weighted 5 trans NA
Sleep duration 0.016 0.00469 6.58e-04 Inverse variance weighted 5 trans NA
Sleep duration 0.016 0.00469 6.58e-04 Inverse variance weighted 5 trans NA
Sleep duration 0.016 0.00469 6.58e-04 Inverse variance weighted 5 cis NA
Sleep duration 0.016 0.00469 6.58e-04 Inverse variance weighted 5 trans NA
Diagnoses - main ICD10: I80 Phlebitis and thrombophlebitis 0.188 0.0733 0.0102 Inverse variance weighted 5 trans NA
Diagnoses - main ICD10: I80 Phlebitis and thrombophlebitis 0.188 0.0733 0.0102 Inverse variance weighted 5 trans NA
Diagnoses - main ICD10: I80 Phlebitis and thrombophlebitis 0.188 0.0733 0.0102 Inverse variance weighted 5 trans NA
Diagnoses - main ICD10: I80 Phlebitis and thrombophlebitis 0.188 0.0733 0.0102 Inverse variance weighted 5 cis NA
Diagnoses - main ICD10: I80 Phlebitis and thrombophlebitis 0.188 0.0733 0.0102 Inverse variance weighted 5 trans NA
Age at menopause 0.219 0.0933 0.0189 Inverse variance weighted 3 trans NA
Age at menopause 0.219 0.0933 0.0189 Inverse variance weighted 3 trans NA
…and 392 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2580_83_2 Myeloperoxidase Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

139 association rows across 64 traits (136 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating MPO levels 3e-475 rs34097845 7 GCST90859948 no MR -> candidate analysis
MPO protein levels 2e-307 rs34097845 6 GCST90469937 no MR -> candidate analysis
Hematological traits (multi-trait analysis) 4e-178 rs34097845 1 GCST90838669 no MR -> candidate analysis
Monocyte percentage (UKB data field 30190) 2e-158 rs34097845 2 GCST90468091 no MR -> candidate analysis
Myeloperoxidase levels 4e-134 rs34097845 5 GCST90012031 no MR -> candidate analysis
Monocyte count 3e-124 rs34097845 8 GCST90002340 no MR -> candidate analysis
Monocyte count (UKB data field 30130) 1e-102 rs34097845 3 GCST90468090 no MR -> candidate analysis
AZU1/MPO protein level ratio 9e-81 rs56378716 1 GCST90313425 no MR -> candidate analysis
CEACAM6 protein levels 5e-76 rs56378716 2 GCST90468697 no MR -> candidate analysis
Monocyte percentage of white cells 7e-71 rs34097845 5 GCST90002394 no MR -> candidate analysis
Neutrophil side scatter 3e-64 rs119468010 2 GCST90281222 no MR -> candidate analysis
Granulocyte percentage of myeloid white cells 9e-57 rs34097845 1 GCST004608 no MR -> candidate analysis
…and 52 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1665 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
myeloperoxidase deficiency 0.874 established (curated) no MR -> candidate analysis
Alzheimer disease type 1 0.798 established (curated) no MR -> candidate analysis
Alzheimer disease 0.195 established (curated) no MR -> candidate analysis
Abnormality of the skeletal system 0.22 common-variant locus no MR -> candidate analysis

Of the 4 rows above, 4 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 1 known modulators (Myeloperoxidase)
gnomAD constraint pLI=2.1e-16, LOEUF=1.02 — LoF-tolerant
GWAS Catalog 105 unique SNPs / 212 rows
ClinVar 177 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance